[ customers have already purchased this product.]   
Share |

Produc Name : Tanezumab

CAS : 880266-57-9

Molecular Formuls : C6464H9942N1706O2026S46 

Molecular Weight : 145.4 kDa

Product Description :
Tanezumab (INN, codenamed RN624) is a monoclonal antibody against nerve growth factor. It was developed by Pfizer as a treatment for pain.
In 2009 there was a Phase III trial for knee pain due to osteoarthritis. Another phase III trial for hip pain in OA was halted in June 2010 when some patients needed hip replacement.
Tanezumab is undergoing Phase II clinical trials for the treatment of various pain entities, including chronic low back pain, bone cancer pain, and interstitial cystitis.

Please feel free to Tanezumabfor: Tanezumab Quotation ( Tanezumab suppliers),COA (Certificate of Analysis), New Sales Promotion,New Products,And any other assistance. Tanezumab

Send to this supplier

 After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@Greenstoneswiss.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6515 7632
4. Send enquiry online:


Customer also maybe viewed the follwing products

Product Image

  • Calcium sulfate
  • Pyridostigmine Deuterated
  • Lauryl glucoside
  • Agrimory Extract
  • Order

    Email us
    Email us
    Email us
    Email us
    Contact Us

    Green Stone Swiss Co ., ltd.

    Email: sales@greenstoneswiss.com

    Tel: +86 592 5365887 

    WhatsApp: +86 189 6515 7632 

    Send an Inquiry, get a discount and complete services.